Metraipolis › archive › dc_20876f31efff

Chemosensitizing effect of apigenin on T-ALL cell therapy — Europe PMC PMID:41244821

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41244821
DOI
10.3389/fphar.2025.1631505
License (as archived)
solo-consultazione
Archived
2026-11-08T22:17:54.510Z
SHA-256 of the archived text
78bc19ad748049b0a42d77ca458f6168ffda6333ad8068795ef0b1c82262aa26
Stable URL of this page
https://metraipolis.com/documento/dc_20876f31efff

How to cite

Chemosensitizing effect of apigenin on T-ALL cell therapy — Europe PMC PMID:41244821 — Europe PMC (en), https://europepmc.org/article/MED/41244821 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_20876f31efff (Metraipolis archive dc_20876f31efff, sha256 78bc19ad748049b0a42d77ca458f6168ffda6333ad8068795ef0b1c82262aa26)
BibTeX
@misc{dc20876f31efff,
  title = {Chemosensitizing effect of apigenin on T-ALL cell therapy — Europe PMC PMID:41244821},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41244821},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_20876f31efff; sha256 78bc19ad748049b0a42d77ca458f6168ffda6333ad8068795ef0b1c82262aa26},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41244821. Agents can read the archived copy with the MCP tool read_document.